pubmed-article:7966237 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7966237 | lifeskim:mentions | umls-concept:C0037224 | lld:lifeskim |
pubmed-article:7966237 | lifeskim:mentions | umls-concept:C0020971 | lld:lifeskim |
pubmed-article:7966237 | lifeskim:mentions | umls-concept:C0021311 | lld:lifeskim |
pubmed-article:7966237 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:7966237 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
pubmed-article:7966237 | lifeskim:mentions | umls-concept:C0024398 | lld:lifeskim |
pubmed-article:7966237 | lifeskim:mentions | umls-concept:C0042212 | lld:lifeskim |
pubmed-article:7966237 | pubmed:issue | 2-3 | lld:pubmed |
pubmed-article:7966237 | pubmed:dateCreated | 1994-12-16 | lld:pubmed |
pubmed-article:7966237 | pubmed:abstractText | Homologous SIVsm stocks were generated by passage of a macaque isolate of SIVsm (SIVsm/E660) in human CEM x 174 cells or macaque peripheral blood mononuclear cells. Macaques were immunized with whole inactivated SIV vaccine consisting of virus generated by transfection of CEM x 174 cells with the SIVsmH4 clone and were challenged with either cell-free stock. Only vaccinees challenged with virus generated in human cells were protected from infection. This confirms the species-specificity of whole inactivated vaccine-mediated protection. | lld:pubmed |
pubmed-article:7966237 | pubmed:language | eng | lld:pubmed |
pubmed-article:7966237 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7966237 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:7966237 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7966237 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7966237 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7966237 | pubmed:issn | 0047-2565 | lld:pubmed |
pubmed-article:7966237 | pubmed:author | pubmed-author:GoldsteinSS | lld:pubmed |
pubmed-article:7966237 | pubmed:author | pubmed-author:LondonW TWT | lld:pubmed |
pubmed-article:7966237 | pubmed:author | pubmed-author:HahnAA | lld:pubmed |
pubmed-article:7966237 | pubmed:author | pubmed-author:MartinJ EJE | lld:pubmed |
pubmed-article:7966237 | pubmed:author | pubmed-author:HirschV MVM | lld:pubmed |
pubmed-article:7966237 | pubmed:author | pubmed-author:ElkinsW RWR | lld:pubmed |
pubmed-article:7966237 | pubmed:author | pubmed-author:GoekenRR | lld:pubmed |
pubmed-article:7966237 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7966237 | pubmed:volume | 23 | lld:pubmed |
pubmed-article:7966237 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7966237 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7966237 | pubmed:pagination | 75-82 | lld:pubmed |
pubmed-article:7966237 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:7966237 | pubmed:meshHeading | pubmed-meshheading:7966237-... | lld:pubmed |
pubmed-article:7966237 | pubmed:meshHeading | pubmed-meshheading:7966237-... | lld:pubmed |
pubmed-article:7966237 | pubmed:meshHeading | pubmed-meshheading:7966237-... | lld:pubmed |
pubmed-article:7966237 | pubmed:meshHeading | pubmed-meshheading:7966237-... | lld:pubmed |
pubmed-article:7966237 | pubmed:meshHeading | pubmed-meshheading:7966237-... | lld:pubmed |
pubmed-article:7966237 | pubmed:meshHeading | pubmed-meshheading:7966237-... | lld:pubmed |
pubmed-article:7966237 | pubmed:meshHeading | pubmed-meshheading:7966237-... | lld:pubmed |
pubmed-article:7966237 | pubmed:meshHeading | pubmed-meshheading:7966237-... | lld:pubmed |
pubmed-article:7966237 | pubmed:meshHeading | pubmed-meshheading:7966237-... | lld:pubmed |
pubmed-article:7966237 | pubmed:meshHeading | pubmed-meshheading:7966237-... | lld:pubmed |
pubmed-article:7966237 | pubmed:meshHeading | pubmed-meshheading:7966237-... | lld:pubmed |
pubmed-article:7966237 | pubmed:articleTitle | Immunization with whole inactivated vaccine protects from infection by SIV grown in human but not macaque cells. | lld:pubmed |
pubmed-article:7966237 | pubmed:affiliation | Immunodeficiency Viruses Section, NIAID, NIH, Rockville, MD 20852. | lld:pubmed |
pubmed-article:7966237 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:7966237 | pubmed:publicationType | Comparative Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7966237 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7966237 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7966237 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7966237 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7966237 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7966237 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7966237 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7966237 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7966237 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7966237 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7966237 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7966237 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7966237 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7966237 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7966237 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7966237 | lld:pubmed |